Back to catalogue
№ 137 13 filings · 2021-09-02 → 2025-12-18

MONKS INVESTMENT TRUST PLC

MNKS
Financial Services Market cap £2.6bn Overall fit 380 /1000

Diluted ~25% AI exposure at fair value (not cheap), minimal structural operating leverage as a fund vehicle, and a 5-year track record of benchmark underperformance disqualify it from the strategy's top bands despite balance-sheet quality and a quantifiable buyback floor.

Fair value range 1,200p–1,400p Mid case · £2.4bn
Absolute upside -6.8% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • NAV-based valuation framework is appropriate and unambiguous for a closed-end fund
  • Full quarterly disclosure of underlying portfolio holdings and discount mechanics
  • Active board-mandated buyback provides quantifiable structural support
Limits the call
  • Spot NAV today differs from 30 April 2025 anchor due to subsequent market moves
  • Fair-discount assumption involves judgement on board commitment to mid-single-digit discount
Methodology

Look-through NAV with sector-typical discount range

In one line · bull case

Diversified global growth-equity trust with ~25% AI-receiver exposure available at roughly NAV, supported by an active buyback programme and very cheap long-dated structural debt — but no operating leverage and a weak benchmark-relative track record.

In one line · biggest risk

Persistent NAV underperformance vs the FTSE World benchmark over 5 years could trigger a manager review or mandate change, while discount widening on macro shocks remains the dominant short-term price risk.

Drivers
AI beneficiary 42 /100
~25% of portfolio sits in AI-related names (NVIDIA, MSFT, Meta, TSMC, semi-equipment additions) but the diluted, fund-level exposure means most AI upside is captured elsewhere.
Operating leverage 20 /100
As a closed-end fund the cost base is already near a structural floor at 0.43% ongoing charge; incremental NAV flows ~1-for-1 plus modest gearing amplification.
Earnings vs expectations 30 /100
Three consecutive years of NAV underperformance vs FTSE World benchmark, including a clear miss in FY25 (+0.1% vs +5.3%).
Growth momentum 40 /100
NAV broadly flat to down in FY25; portfolio earnings growth forecast at ~12.5% p.a. is healthy but not accelerating.
Moat 20 /100
No moat as a vehicle; Baillie Gifford's brand and Global Alpha team are credentials but the 5-year benchmark gap has dented them.
Earnings quality 75 /100
NAV is marked-to-market with full Level 1/2/3 disclosure; clean reporting and independent S&P Global private valuation oversight.
Management quality 45 /100
Mixed: Board has been disciplined on buybacks and cost (refinanced facility, structural debt at low rates) but the underlying manager has materially missed benchmark over 3-5 years.
Cyclicality 70 /100
Diversified global equity fund highly correlated to global market moves; the April-2025 tariff sell-off wiped out 10 months of gains in weeks.
Leverage 30 /100
Net gearing 8.9% at a blended 3.6% rate, with long-dated structural debt locked in at sub-2% — a conservative, well-structured balance sheet.
Value-trap signals · 4
  • 5-year NAV underperformance vs FTSE World benchmark
  • Sharp FY25 dividend cut from 2.10p to 0.50p (mechanical but signal-worthy)
  • Repeated references to process refinements suggest the manager is still recovering
  • Chairman transition and ongoing Board refreshment introduce governance transition risk

Monks Investment Trust PLC (MNKS) — Research Note

Executive summary

Monks is a £2.3bn global growth-equity investment trust managed by Baillie Gifford's Global Alpha team, holding ~100 listed and a sliver of unlisted positions across "stalwart", "rapid" and "cyclical" growth buckets. Across the 5-year period, the trust has materially underperformed its FTSE World benchmark (NAV up +0.1% in FY25 vs index +5.3%, and behind over 5 years), prompting an aggressive 27.7%-of-shares buyback programme and a refresh of process 2025-07 annual. The single most important valuation point is that this is a closed-end fund where fair value = portfolio NAV, currently trading near it — so the only "edge" available to a buyer is the persistent discount (10.1% at year-end, narrower since) and indirect exposure to AI receivers via a diluted ~25% portfolio slug 2025-07 annual.

Fair value estimate

Methodology: NAV-based. For an investment trust, fair value is the look-through portfolio NAV, optionally discounted for the typical sector discount on global-growth ITs.

Key anchors:

  • NAV per share at 30 April 2025 (borrowings at fair value): 1,265.2p 2025-07 annual
  • NAV per share at 31 October 2024: 1,344.1p 2024-12 interim
  • The April-2025 NAV reflects a Trump-tariff-driven 20% S&P drawdown right before year-end — i.e. the spot NAV today is highly likely to be materially higher than 1,265.2p, given the subsequent market recovery
  • Board has signalled it intends to defend a mid-single-digit discount under normal conditions 2025-07 annual

Fair value range, expressed per share:

  • Low (5–7% discount to a conservative ~1,300p estimated current NAV): ~1,200p
  • High (zero discount on a recovered NAV near 1,400p): ~1,400p
  • Midpoint: ~1,300p

Implied market-cap range (using ~185m shares outstanding post-buybacks):

  • Low: ~£2,220m
  • High: ~£2,590m
  • Mid: ~£2,405m

Comparison vs latest disclosed market cap of £2,427.9m: roughly fair value. Absolute upside/downside is essentially zero (-1% to mid). View: fair. There is no margin of safety here; the discount has already narrowed materially from the highs.

Sector context

Sector classification confirmed: Financials / Financial Services / closed-end equity investment trust. Quality profile is high (Baillie Gifford manager, low 0.43% ongoing charge, modest 8.9% gearing at very attractive 3.6% blended rate, structural debt locked in at 1.86%/1.77% out to 2045–2054), but the 5-year performance record is below typical peers. Comparable listed peers: Scottish Mortgage Investment Trust (SMT) — same manager, more concentrated, higher unlisted exposure; Alliance Trust (ATST) and F&C Investment Trust (FCIT) — diversified global equity trusts with similar mandate, generally trading at narrower discounts.

Investment thesis (3 bullets)

  • Indirect AI-receiver exposure at fair value. ~25% of the portfolio is invested in "companies that power, build or benefit from AI" — NVIDIA (3.1%), Microsoft (4.1%), Meta (4.0%), TSMC (3.2%), plus semi-equipment additions Disco Corp and Kokusai Electric, and Salesforce's Agentforce play 2025-07 annual. The buyer gets diversified picks-and-shovels exposure without paying a single-stock AI premium.
  • Persistent discount + active buyback floor. Board bought back 26.5m shares (12.4% of opening count) at £321m and an average 10% discount in FY25; cumulative buyback now £727m / 27.7% of the Jan-2022 share count, and the Board has explicitly stated it will tighten the discount toward mid-single digits 2025-07 annual. This is a quantifiable structural tailwind to per-share NAV.
  • Fortress-like balance-sheet financing. Long-dated structural debt at 1.86% (2054), 1.77% (2045), plus euro/yen notes — blended cost just 3.6% and covenants comfortable. The decision to lock in this debt during 2020–23 looks excellent in hindsight and gives the trust a multi-decade cost-of-capital advantage 2025-07 annual.

Key risks (3 bullets)

  • 5-year underperformance vs benchmark is now structural enough to raise Manager-review risk. The Chairman explicitly flagged that the Board will be "considering this issue in even greater detail" given they are behind the index over 5 years 2025-07 annual. A change of manager or mandate could be value-destructive in the short term.
  • AI exposure is diluted by long tail of small positions and questionable healthcare picks. Outside the top names, the portfolio includes 103 holdings, an incubator tail of <0.5% positions, and healthcare detractors (Elevance, Novo Nordisk, Moderna sold) that subtracted 3+% of relative performance in FY25 2025-07 annual. The AI-receiver story is real but heavily diluted.
  • Discount can widen again on macro shocks. The Trump "Liberation Day" tariff event in April 2025 drove the discount from 8.5% to 10.1% in weeks 2025-07 annual. Discount volatility, not portfolio quality, is the dominant short-term risk for shareholders.

Operating leverage

Effectively none on the trust itself. Monks is a closed-end fund: its cost base is dominated by the tiered management fee (0.45% / 0.33% / 0.30% — total £9.7m in FY25) plus £1.965m other admin and £8.5m finance costs. Cost-to-NAV ratio is 0.43% and is already near the structural floor. Incremental NAV growth flows ~1-for-1 to per-share NAV, lightly amplified by the 8.9% net gearing — a 20% portfolio rally translates to ~22% NAV uplift, not 2x or 3x 2025-07 annual. Buybacks at a discount add a modest mechanical lift (FY25 buybacks added ~1.1% to NAV per share). The portfolio's underlying companies have varying operating leverage (Meta, NVIDIA, Microsoft are high-leverage; CRH, Martin Marietta are moderate), but as a vehicle, MNKS does NOT give the "incremental revenue → multiple of profit" payoff the investor profile is targeting. For that, single-name semi/AI plays are required.

Value-trap signals

  • 5-year underperformance vs the benchmark (NAV +163.3% vs FTSE World +182.0% on a 10-year basis under current team; behind over 5 years on the team's own disclosure) 2025-07 annual
  • Dividend cut from 2.10p (FY24) to 0.50p (FY25) — although this is mechanical (to preserve buyback headroom under investment-trust rules), it is a signal worth flagging
  • Repeated process changes ("strengthened analytical inputs around valuations and stock correlations" referenced in FY23 and FY24 reports) suggest the manager has had to adapt
  • Chairman departure and Board succession at AGM 2025 introduces governance transition risk

Earnings vs expectations

Investment trusts don't issue earnings guidance in the corporate sense, but the relevant analogue is NAV total return vs the FTSE World benchmark:

  • FY23 (Apr-2023): NAV (fair) -1.6% vs index +3.2% — MISS
  • FY24 (Apr-2024): NAV (fair) +17.6% vs index +19.1% — narrow MISS at NAV, share price matched at +19.1%
  • H1 FY25 (Oct-2024): NAV (fair) +6.3% vs index +8.1% — MISS
  • FY25 (Apr-2025): NAV (fair) +0.1% vs index +5.3% — clear MISS 2025-07 annual

The pattern is three consecutive years of NAV underperformance, partially mitigated by share-price discount narrowing in FY24 only. This is a meaningful and persistent miss vs the benchmark — the manager is in the third year of trying to recover.

Conviction

4 — high. Methodology is unambiguous (NAV is the right valuation anchor for a closed-end fund), the trust discloses its underlying portfolio in full at half-year and year-end, and the current price sits within a tight band of recently disclosed NAV. Conviction anchors: clean NAV reporting with both par-value and fair-value debt adjustments; detailed look-through to all 100+ holdings; clear quantification of discount, gearing and buyback activity. Conviction caveats: the spot NAV today differs from the 30-April-2025 anchor because of intervening market moves, and the right "fair discount" assumption involves judgement on Board buyback intensity. Not a 5 because of these timing/discount uncertainties; not a 3 because the framework is otherwise tight.

Filings consulted · 14

Every document the LLM read for this note. Click any row to open the source.

  1. 2025-12-18Half Year Financial Report2025-12-18_9306768_half-year-financial-report.md0.90
  2. 2025-09-09Result OF Agm2025-09-09_9096986_result-of-agm.md0.26
  3. 2025-07-02The Monks Investment Trust Plc Annual Results2025-07-02_8958657_the-monks-investment-trust-plc-annual-results.md0.85
  4. 2024-12-18Half Year Report2024-12-18_8619025_half-year-report.md0.58
  5. 2024-12-04Monks Investment Trust Plc Half Year Results2024-12-04_8588650_monks-investment-trust-plc-half-year-results.md0.58
  6. 2024-09-10Result OF Agm2024-09-10_8409506_result-of-agm.md0.20
  7. 2024-07-02Monks Investment Trust Annual Results2024-07-02_8289089_monks-investment-trust-annual-results.md0.65
  8. 2023-12-08The Monks Investment Trust Plc Interim Results2023-12-08_7929693_the-monks-investment-trust-plc-interim-results.md0.41
  9. 2023-09-07Result OF Agm2023-09-07_7742343_result-of-agm.md0.14
  10. 2023-06-20Monks Investment Trust Plc Full Year Results2023-06-20_7582372_monks-investment-trust-plc-full-year-results.md0.45
  11. 2022-12-07Monks Investment Trust Plc Half Year Report2022-12-07_7321140_monks-investment-trust-plc-half-year-report.md0.23
  12. 2022-09-06Result OF Agm2022-09-06_7213124_result-of-agm.md0.07
  13. 2021-12-07Half Year Report2021-12-07_6754331_half-year-report.md0.23
  14. 2021-09-02Result OF Agm2021-09-02_6717871_result-of-agm.md0.07

This research note was authored by a large language model after reading 13 regulatory filings published between 2021-09-02 and 2025-12-18. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.